Alliance of Infinity Trade
Cefoperazone + Sulbactam Vial Range.
Introducing AIT Pharmaceuticals Division’s Cefoperazone + Sulbactam Vial Range
At AIT Pharmaceuticals Division, we are committed to advancing healthcare by providing high-quality pharmaceutical products. Our Cefoperazone + Sulbactam Vial Range combines the potent antibacterial activity of cefoperazone with the beta-lactamase inhibitor sulbactam, offering a powerful solution for combating multidrug-resistant bacterial infections.
Drug Classification: Cefoperazone + Sulbactam is classified as a combination antibiotic. Cefoperazone belongs to the third-generation cephalosporin class, while sulbactam is a beta-lactamase inhibitor.
Share
Formulations:
- Cefoperazone + Sulbactam Vial: Available in strengths of 1gm and 2gm, our vials contain a sterile powder for reconstitution, providing flexibility in dosage administration.
Indications:
- Our Cefoperazone + Sulbactam Vial is indicated for the treatment of:
- Severe intra-abdominal infections
- Respiratory tract infections, including pneumonia and bronchitis
- Urinary tract infections
- Skin and soft tissue infections
- Septicemia and meningitis caused by susceptible organisms
Pharmacokinetics:
- Absorption: Cefoperazone and sulbactam are administered parenterally and are rapidly absorbed after intravenous injection.
- Distribution: Both drugs achieve high concentrations in various body tissues and fluids, including the lungs, kidneys, and cerebrospinal fluid.
- Metabolism: Cefoperazone undergoes minimal metabolism in the liver, while sulbactam is primarily excreted unchanged in the urine.
- Elimination: The elimination half-life of cefoperazone is approximately 1-2 hours, while sulbactam has a shorter half-life of about 0.5-1 hour.
Pharmacodynamics:
- Cefoperazone inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death.
- Sulbactam acts as a beta-lactamase inhibitor, preventing the inactivation of cefoperazone by bacterial beta-lactamases and enhancing its antibacterial activity against beta-lactamase-producing strains.
Usage:
- Our Cefoperazone + Sulbactam Vial is intended for intravenous administration by healthcare professionals trained in the proper handling and reconstitution of injectable medications.
Dosage:
- The recommended dosage of Cefoperazone + Sulbactam varies depending on the type and severity of the infection, as well as the patient’s age, weight, and renal function.
- Dosage adjustments may be necessary in patients with impaired renal function to prevent drug accumulation and toxicity.
Side Effects:
- Common side effects of Cefoperazone + Sulbactam may include:
- Nausea
- Diarrhea
- Injection site reactions
- Hypersensitivity reactions, including rash and itching
- Serious side effects such as anaphylaxis and pseudomembranous colitis may occur, although they are rare.
Experience the effectiveness and reliability of AIT Pharmaceuticals Division’s Cefoperazone + Sulbactam Vial Range in the treatment of severe bacterial infections. For more information, please contact us.
Reviews
There are no reviews yet.